Leading Chinese Biotech Company Innovent Is on Track to Profitability
Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...
The Manila Times23h
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
Alvotech (NASDAQ: ALVO, or the "Company”), a global biotech company specializing in the development and manufacture of ...
Pharmaceutical Technology21h
AGA overhauls UC treatment pathway: early, high-efficacy therapies now preferred
In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the ...
Alvotech Reports Record Results for 2024 and Provides Business Update
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, representing a 462% increase over prior yearAdjusted EBITDA in ...